PhaseV unveils centralised platform to automate clinical trials
PhaseV has launched the AI Conductor centralised platform designed to automate every stage in the clinical trial process from drafting protocols…
All articles by Salong Debbarma
Salong Debbarma
-
-
START and Trialing collaborate on oncology clinical trials
The START Center for Cancer Research (START) has entered a partnership with Trialing, aimed at increasing oncology clinical trial access…
-
Mirum concludes Phase III EXPAND trial enrolment for Livmarli
Mirum Pharmaceuticals has completed enrolment in the Phase III EXPAND study assessing Livmarli (maralixibat) for patients aged six months and…
-
GEN secures BEBO Foundation approval for Phase II PD trial
GEN Pharmaceuticals has secured the BEBO Foundation approval for the ethical assessment of biomedical research to initiate a Phase II…
-
YolTech Therapeutics gains FDA approval for Phase II/III AATD trial
YolTech Therapeutics has received clearance from the US Food and Drug Administration (FDA) to begin a Phase II/III clinical study…
-
J&J reports positive data for Erda-iDRS in bladder cancer
Johnson & Johnson (J&J) has reported encouraging results from a Phase I study of the investigational intravesical drug-releasing system, Erda-iDRS…
-
Virta Health reports improved outcomes in pancreatic cancer trial
Virta Health has reported improved outcomes from its Phase II randomised controlled trial (RCT), which examined the impact of its…
-
Pilatus Biosciences doses first patient in PLT012 antibody trial
Pilatus Biosciences has announced the dosing of the first patient in its Phase I clinical trial of PLT012, a first-in-class…
-
Patient enrolment concludes in Spinogenix’s Phase II schizophrenia trial
US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known…
-
Gesynta Pharma doses first patient in Phase II NOVA trial
Gesynta Pharma has dosed the first patient in its Phase II trial, NOVA, investigating vipoglanstat, a non-hormonal, non-opioid drug for…